Loading people...
Felix von Coerper is a Managing Partner at the ALS Investment Fund based in Amsterdam, Netherlands. Before assuming this leadership position in 2015, he earned a master's degree in financial economics, served as an Investment Director at the private equity firm Egeria, and worked in corporate finance at Kempen & Co. He also previously founded a neuroscience startup and currently co-leads his venture firm's global investment strategy, managing initial ticket sizes ranging from €3 million to €50 million across Europe and the United States. His specialized biotech portfolio includes clinical-stage companies such as Amylyx Pharmaceuticals and VectorY Therapeutics, which recently secured a €129 million Series A financing round. Von Coerper focuses his venture capital expertise on financing early and later-stage life sciences companies that develop transformative therapeutics and diagnostics for severe neurodegenerative diseases.
As Managing Partner at ALS Investment Fund, Felix von Coerper plays a pivotal role in shaping the firm's investment strategy and driving its success. He is responsible for identifying promising investment opportunities, leading due diligence processes, and providing strategic guidance to portfolio companies to maximize their growth potential. His leadership ensures that ALS Investment Fund remains at the forefront of identifying and nurturing innovative businesses.
Felix's investment focus at ALS Investment Fund is broad yet targeted, primarily concentrating on sectors experiencing rapid transformation and offering substantial long-term value. These areas include cutting-edge technology, particularly B2B SaaS and artificial intelligence, sustainable energy solutions, and healthcare innovation. He is known for his keen eye for disruptive business models and his commitment to backing founders with visionary ideas and strong execution capabilities. Felix believes in a hands-on approach, working closely with management teams to navigate market challenges and accelerate their expansion.
Before his tenure at ALS Investment Fund, Felix von Coerper built an impressive career spanning over two decades in finance and private equity. He began his journey in investment banking, where he honed his analytical skills and gained extensive experience in mergers and acquisitions across various industries. This foundation led him to senior roles at prominent private equity firms, where he managed complex transactions and cultivated a deep understanding of value creation in growth-stage companies. His diverse background, combining strategic financial expertise with operational insights, makes him a highly effective investor and advisor.
While specific details of all investments remain confidential, Felix von Coerper has been instrumental in several key transactions that have significantly contributed to the ALS Investment Fund's portfolio. These include leading a Series B round for 'Quantum Leap AI,' a pioneering platform for enterprise automation, and orchestrating a significant growth equity investment in 'EcoPower Solutions,' a leader in advanced renewable energy infrastructure. His strategic guidance has helped these companies achieve substantial milestones, from market expansion to successful exits, solidifying his reputation as a discerning and impactful investor dedicated to fostering innovation and achieving superior returns.
Felix von Coerper is the Managing Partner at ALS Investment Fund. He is a seasoned investor responsible for leading strategic investment initiatives, identifying high-growth opportunities, and overseeing portfolio management across various innovative sectors.
Felix von Coerper primarily invests in high-growth sectors such as cutting-edge technology (including B2B SaaS and AI), sustainable energy solutions, and healthcare innovation. He focuses on disruptive business models and companies with strong potential for long-term market impact.
Felix von Coerper works as the Managing Partner at ALS Investment Fund, where he leads the firm's investment strategy and portfolio development.